Literature DB >> 18081617

Sociodemographic and clinical factors associated with relapse in schizophrenia.

Gobind Chabungbam1, Ajit Avasthi, Pratap Sharan.   

Abstract

The aim of the present study was to examine sociodemographic and clinical factors associated with relapse in schizophrenia. The study group consisted of a convenience sample of 40 schizophrenia patients (20 patients each in relapse and remission). Relapse and remission were defined based on clinical criteria (ICD-10 criteria, course since last episode, and duration of remission) and psychometric criteria (scores on Socio-Occupational Functioning Assessment Scale [SOFAS] and Positive and Negative Syndrome Scale for Schizophrenia [PANSS]). The index group was evaluated after the occurrence of current relapse but within 6 months of its onset. Sociodemographic, current psychopathology (PANSS) and functioning (SOFAS), and other (mainly retrospective) variables were assessed with a specifically designed clinical profile sheet, Schedule for Affective Disorders and Schizophrenia Lifetime version, Presumptive Stressful life Events Scale, and World Health Organization Life Chart Schedule for Assessment of Course and Outcome of Schizophrenia. Patients who had relapsed were more symptomatic and exhibited greater dysfunction in comparison to remitted patients. Relapse in schizophrenia was significantly associated with unemployment, number of psychotic episodes, side-effects of medication, and life events score. The present findings suggest that a severe illness (no. psychotic episodes, unemployment), psychological stress and inappropriate treatment (side-effects of medicines) may be causally related to relapse in schizophrenia. However, the possibility that these variables may be caused by relapse or may be explained by a common underlying variable needs to be assessed prospectively.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18081617     DOI: 10.1111/j.1440-1819.2007.01722.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  15 in total

1.  Case Report: Schizophrenia Discovered during the Patient Interview in a Man with Shoulder Pain Referred for Physical Therapy.

Authors:  Nirtal Shah; Yuka Nakamura
Journal:  Physiother Can       Date:  2010-10-18       Impact factor: 1.037

2.  What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial.

Authors:  Rebecca Schennach; Michael Riedel; Michael Obermeier; Ilja Spellmann; Richard Musil; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-27       Impact factor: 5.270

Review 3.  Functional outcomes in schizophrenia: employment status as a metric of treatment outcome.

Authors:  Rebecca Schennach; Richard Musil; Hans-Jürgen Möller; Michael Riedel
Journal:  Curr Psychiatry Rep       Date:  2012-06       Impact factor: 5.285

4.  Personality traits predicting quality of life and overall functioning in schizophrenia.

Authors:  Caitlin Ridgewell; Jennifer Urbano Blackford; Maureen McHugo; Stephan Heckers
Journal:  Schizophr Res       Date:  2016-10-13       Impact factor: 4.939

5.  Differences in Symptom Severity and Independent Living Skills Between Re-hospitalized and Not Re-hospitalized Individuals with Schizophrenia: A Longitudinal Study.

Authors:  Peter Ji; Anthony Menditto; Niels C Beck; Paul R Stuve; Jason Reynolds
Journal:  Community Ment Health J       Date:  2018-03-22

6.  Race and long-acting antipsychotic prescription at a community mental health center: a retrospective chart review.

Authors:  Neil Krishan Aggarwal; Robert A Rosenheck; Scott W Woods; Michael J Sernyak
Journal:  J Clin Psychiatry       Date:  2012-04       Impact factor: 4.384

7.  High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People's Republic of China.

Authors:  Jingbo Xiao; Weifeng Mi; Lingzhi Li; Ying Shi; Hongyan Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-08       Impact factor: 2.570

Review 8.  Impacts of stress and sex hormones on dopamine neurotransmission in the adolescent brain.

Authors:  Duncan Sinclair; Tertia D Purves-Tyson; Katherine M Allen; Cynthia Shannon Weickert
Journal:  Psychopharmacology (Berl)       Date:  2014-01-31       Impact factor: 4.530

9.  Quality of life is predictive of relapse in schizophrenia.

Authors:  Laurent Boyer; Aurelie Millier; Emeline Perthame; Samuel Aballea; Pascal Auquier; Mondher Toumi
Journal:  BMC Psychiatry       Date:  2013-01-09       Impact factor: 3.630

10.  Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review.

Authors:  José M Olivares; Jan Sermon; Michiel Hemels; Andreas Schreiner
Journal:  Ann Gen Psychiatry       Date:  2013-10-23       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.